1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Massachusetts >
  6. Catalent Acquires Acorda Therapeutics - Manufacturing & Packaging Operations

M&A Deal Summary

Catalent Acquires Acorda Therapeutics - Manufacturing & Packaging Operations

On January 13, 2021, Catalent acquired manufacturer Acorda Therapeutics - Manufacturing & Packaging Operations from Acorda Therapeutics

Acquisition Highlights
  • This is Catalent’s 1st transaction in the Manufacturing sector.
  • This is Catalent’s 7th transaction in the United States.
  • This is Catalent’s 2nd transaction in Massachusetts.

M&A Deal Summary
Date 2021-01-13
Target Acorda Therapeutics - Manufacturing & Packaging Operations
Sector Manufacturing
Buyer(s) Catalent
Sellers(s) Acorda Therapeutics
Deal Type Divestiture

Target

Acorda Therapeutics - Manufacturing & Packaging Operations

Chelsea, Massachusetts, United States
Acorda Therapeutics' Manufacturing & Packaging Operations provides spray drying capacity, including GEA NIRO® PSD-1, PSD-4, and PSD-7 spray drying unit.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Catalent

Somerset, New Jersey, United States
Category Company
Founded 2007
Sector Life Science
Revenue 4.3B USD (2023)
DESCRIPTION

Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

DEAL STATS #
Overall 13 of 16
Sector: Manufacturing M&A 1 of 1
Type: Divestiture M&A Deals 5 of 6
State: Massachusetts M&A 2 of 2
Country: United States M&A 7 of 9
Year: 2021 M&A 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-29 Skeletal Cell Therapy Support SA

Charleroi, Belgium

Skeletal Cell Therapy Support SA owns and operates a purpose-built CGxP facility of approximately 41,000 square-foot (3,800 square-meter), including its related quality control and product development laboratories, warehouse, grade C, and B cleanrooms and equipment as well as land for further development. Skeletal Cell Therapy Support is based in Charleroi, Belgium.

Buy €12M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-23 Delphi Genetics SA

Gosselies, Belgium

Delphi Genetics SA is a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO). Delphi Genetics was founded in 2001 and is based in Gosselies, Belgium.

Buy -

Seller(S) 1

SELLER

Acorda Therapeutics

Pearl River, New York, United States
Category Company
Founded 1995
Sector Life Science
Employees102
Revenue 118M USD (2023)
DESCRIPTION

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis and related neurological conditions such as spinal cord injury (SCI). Acorda Therapeutics was founded in 1995 and is headquartered in Pearl River, New York.

DEAL STATS #
Overall 2 of 2
Sector: Manufacturing M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
State: Massachusetts M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-05 Acorda Therapeutics - Qutenza

Ardsley, New York, United States

Acorda Therapeutics, Inc. - Qutenza is a pain product. A single, 1-hour, localized treatment with this patch may provide at least 3 months of relief from for example post-shingles nerve pain.

Sell -
Mergr

Solution for

Product

Company

Legal